Drug Topics

SEPTEMBER 15, 2023

The mRNA-1010 vaccine generated a powerful response against 4 influenza virus strains compared to traditional flu shots.

Vaccines 360

Vaccines 360

Pharmacy Times

SEPTEMBER 15, 2023

Study results could lead to an FDA approval for MDMA to treat post-traumatic stress disorder by the end of 2023.

FDA 152

FDA 152

Drug Topics

SEPTEMBER 15, 2023

The American Diabetes Association's 2023 “Children and adolescents: standards of care in diabetes” highlights risk factors and treatment for type 1 and type 2 diabetes.

247

247

Pharmacy Times

SEPTEMBER 15, 2023

The CEO of Yseop discusses how AI can have a positive impact in the development of high quality medical writing due to its efficiency and ability to reduce long, tedious tasks for writers.

152

152

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

SEPTEMBER 15, 2023

The perfluorohexyloctane ophthalmic solution from Bausch + Lomb was approved by the FDA in May and will have a whole acquisition cost of $771 for a one-month supply.

FDA 247

FDA 247

Pharmacy Times

SEPTEMBER 15, 2023

Although antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.

149

149

STAT

SEPTEMBER 15, 2023

In order to provide gender-affirming care, clinicians must sometimes jump through unusual hoops. In Australia, for example, the government won’t subsidize testosterone treatment for a trans man without a peculiar bureaucratic maneuver; a doctor must say the patient has a testicular disorder. The disorder: Trans men, being trans, are born without testes.

143

143

pharmaphorum

SEPTEMBER 15, 2023

FTC fires shot across pharma's bows over 'improper' patents Phil.

140

140

STAT

SEPTEMBER 15, 2023

There is just not enough Wegovy. The current manufacturing shortage will eventually end, and those who have health insurance that covers Wegovy, plus the even luckier ones who can afford to pay out of pocket, will once again get their medication.

Insurance 142

Insurance 142

Pharmacy Times

SEPTEMBER 15, 2023

As research and clinical experience continue, Hemangeol's role in the management of infantile hemangioma is likely to expand, further improving the lives of affected children.

139

139

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 15, 2023

Boston isn’t the only city slated for a new cancer center. Far from it. There’s little appetite to build general acute-care hospitals, especially as their financial outlook dims and more services move outpatient. So on its face, Dana-Farber Cancer Institute’s plan to build a new cancer hospital with Beth Israel Deaconess Medical Center seems peculiar.

Hospitals 135

Hospitals 135

Fierce Healthcare

SEPTEMBER 15, 2023

Kroger Health, part of the Kroger Co., is teaming up with Performance Kitchen to offer medically tailored meals to people with chronic conditions. | Performance Kitchen’s team of chefs, doctors and registered dietitians focuses on delivering nutritionally balanced meals. The meals will be both approved by Performance Kitchen’s team and Kroger Health registered dietitians.

133

133

Pharmacy Times

SEPTEMBER 15, 2023

A collaborative exercise with 16 health care organizations nets millions in savings.

132

132

Fierce Healthcare

SEPTEMBER 15, 2023

Ascension closed out its 2023 fiscal year with a $2.66 billion net loss, according to financial disclosures for the period ended June 30. | Discarding a $1.5 billion one-time write-down still left the Catholic giant with a $1.55 billion loss from recurring operations.

130

130

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

SEPTEMBER 15, 2023

Forecasts from the biggest pharma companies follow a pattern of thinking big and manifesting the desired outcome.

130

130

Fierce Healthcare

SEPTEMBER 15, 2023

Worsening mental health among young people is a growing national concern, and, in a bid to tackle the issue in its home state of Michigan, insurer Priority Health is going to the dogs—literally.

Insurance 130

Insurance 130

STAT

SEPTEMBER 15, 2023

South African authorities are investigating Johnson & Johnson and its Janssen subsidiary over “excessive pricing” of a lifesaving tuberculosis drug, the latest imbroglio to engulf the company of its medicine. In a brief statement , the South African Competition Commission confirmed that it lodged a complaint earlier this week against the health care giant over its TB medicine, bedaquiline , which is also sold under the Sirturo brand name.

127

127

Fierce Healthcare

SEPTEMBER 15, 2023

There is no shortage of unjust elements in the U.S. healthcare system. But one in particular deserves far more attention and action than it is currently receiving—namely, medical debt. | As healthcare leaders, we believe there is a moral obligation to take action to reduce the burden of medical debt, and there are obvious levers to help.

128

128

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

SEPTEMBER 15, 2023

Bispecific antibodies have 2 distinct binding domains, which interact with either CD3 on T cells or a tumor-associated antigen on the tumor cell surface.

123

123

pharmaphorum

SEPTEMBER 15, 2023

Driving data & analytics transformation in life sciences Mike.

122

122

Pharmacy Times

SEPTEMBER 15, 2023

As a once-daily oral treatment, orforglipron could help address barriers to injectable medications, such as semaglutide and liraglutide.

123

123

STAT

SEPTEMBER 15, 2023

This column is from Trendlines, a business newsletter that covers the forces shaping the economy in Boston and beyond. If you’d like to receive it via email on Mondays, Wednesdays, and Fridays,  sign up here. I t’s Boston’s biggest divorce since Gisele and Tom split, but this one is epically acrimonious and has real-life repercussions for the region’s hospital industry and its patients.

Hospitals 120

Hospitals 120

European Pharmaceutical Review

SEPTEMBER 15, 2023

The CBL-0201DD Phase II study evaluating the first-in-class small-molecule drug CBL-514 for Dercum’s disease, a rare disorder, has demonstrated significant efficacy in reducing lipoma size and complete clearance. Dercum’s disease is characterised by painful lipomas developing primarily on the trunk in the body. Currently there are no approved or effective medicine, so the data from the Phase II study shows potential of a treatment for this indication.

Compounding 119

Compounding 119

Fierce Pharma

SEPTEMBER 15, 2023

Questions first circulated about decongestant pills containing phenylephrine in 2007. | Several companies, including Johnson & Johnson, GSK, Procter & Gamble and Walgreens, face class-action lawsuits that claim the drugmakers knew that over-the-counter cold and flu pills containing phenylephrine did not work as advertised.

113

113

European Pharmaceutical Review

SEPTEMBER 15, 2023

For its 20 th anniversary, more than 180 entries across 12 categories have been narrowed down to determine the finalists the upcoming CPHI Pharma Awards. To recognise the influx of innovation across the pharmaceutical industry, three new categories are included in this year’s awards. The shortlisted finalists of the CPHI awards for 2023 include companies that led by example in sustainable manufacturing, manufacturers and innovators that developed new technologies to advance drug discovery, devel

Packaging 119

Packaging 119

STAT

SEPTEMBER 15, 2023

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We plan to spend time observing ancient rituals, promenading with the official mascots, and napping and, if time permits, we will close out with a listening party.

Hospitals 112

Hospitals 112

pharmaphorum

SEPTEMBER 15, 2023

FDA capacity forces delay to Iovance's cell therapy Phil.

FDA 111

FDA 111

Fierce Healthcare

SEPTEMBER 15, 2023

Boston-based Dana-Farber Cancer Institute and Beth Israel Deaconess Medical Center (BIDMC) announced plans to build an independent, freestanding cancer hospital—a first-in-the-region move with rami | The collaboration will yield the Boston area's only free-standing adult cancer hospital. It also rewrites a longtime affiliation between Dana-Farber Cancer Institute and another of the region's major healthcare players, Brigham and Women's Hospital.

Hospitals 111

Hospitals 111

pharmaphorum

SEPTEMBER 15, 2023

Double IPOs headline this week's biotech financings Phil.

110

110

Fierce Healthcare

SEPTEMBER 15, 2023

The U.S. | Experts were brought to the hill to explain the root causes of drug shortages, plus how potential legislation could remedy the problem.

111

111

STAT

SEPTEMBER 15, 2023

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them.  Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

106

106

Fierce Healthcare

SEPTEMBER 15, 2023

There’s been a lot of churn at Blue Cross Blue Shield of Michigan (BCBSM) this week. | Daniel J. Loepp, the president and CEO of Blue Cross Blue Shield of Michigan, announced his departure date the day after workers at the insurer went on strike.

Insurance 105

Insurance 105

Pharmaceutical Technology

SEPTEMBER 15, 2023

The company is also planning to expand its Phase I/II PRODYGY lead candidate trial in retinitis pigmentosa to three more US sites.

105

105